Reckitt Benckiser Group plc (LON:RKT – Get Free Report)’s share price was down 1.1% on Friday . The stock traded as low as GBX 4,600 ($60.20) and last traded at GBX 4,626 ($60.54). Approximately 910,732 shares were traded during mid-day trading, a decline of 73% from the average daily volume of 3,421,452 shares. The stock had previously closed at GBX 4,676 ($61.20).
Analyst Ratings Changes
RKT has been the topic of a number of recent analyst reports. Jefferies Financial Group reiterated a “hold” rating and set a GBX 4,400 ($57.58) price target on shares of Reckitt Benckiser Group in a research report on Monday, July 29th. JPMorgan Chase & Co. lowered Reckitt Benckiser Group to a “neutral” rating in a research report on Friday, August 30th. Finally, Berenberg Bank boosted their price target on shares of Reckitt Benckiser Group from GBX 5,100 ($66.75) to GBX 5,200 ($68.05) and gave the stock a “hold” rating in a report on Wednesday, July 24th.
Get Our Latest Stock Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Trading Down 1.1 %
Reckitt Benckiser Group Cuts Dividend
The firm also recently declared a dividend, which was paid on Friday, September 13th. Stockholders of record on Thursday, August 1st were paid a GBX 80.40 ($1.05) dividend. This represents a dividend yield of 1.82%. The ex-dividend date was Thursday, August 1st. Reckitt Benckiser Group’s dividend payout ratio is currently 9,032.26%.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Read More
- Five stocks we like better than Reckitt Benckiser Group
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- Learn Technical Analysis Skills to Master the Stock Market
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- Health Care Stocks Explained: Why You Might Want to Invest
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.